Where oral therapy is not feasible or is temporarily undesirable in the judgement of the physician, Flamicort injection 40 mg/ml is indicated for intramuscular use as follows:
- Allergic diseases
- Rheumatic disorders, as adjunctive therapy for short-term administration (to tide the patient over an acute episode exacerbation) in: post-traumatic osteoarthritis, synovitis of osteoarthritis, rheumatoid arthritis, acute or sub-acute bursitis, epicondylitis, acute nonspecific tenosynovitis, acute gouty arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile rheumatoid arthritis.
- Collagen diseases, during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus, acute rheumatic carditis.
- Dermatological diseases, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe psoriasis.
- Edematous state, to induce diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.
Triamcinolone 40 mg
0 to 6 Years Old
Insufficient clinical experience with Flamicort intramuscular injection to recommend its use in children under six years of age.
6 to 12 Years Old
Dosage depends more on the severity of symptoms than on age or weight.
12 Years Old and Above
60 mg injected deeply into the gluteal muscle.
Dosage is usually adjusted within the range of 40-80 mg, depending upon patient’s response and duration of relief. Some patients may be well controlled on dosages as low as 20 mg or less.